Therapeutic Action
Opioid analgesic
Source page 99
Loading InternPractice…
Individual generic drug information
Extracted information for CODEINE only.
Opioid analgesic
Source page 99
Moderate pain, alone or in combination with a non-opioid analgesic
Source page 99
Extracted information for CODEINE only.
Do not administer to patients with acute respiratory depression or asthma attack. May cause: constipation, nausea, vomiting, drowsiness, dizziness; rarely: respiratory depression, allergic reactions, dependence, withdrawal syndrome. Do not combine with: other agonist opioids such as morphine (increased risk of respiratory depression); agonist-antagonist opioids such as buprenorphine, nalbuphine, pentazocine (competitive action). Management of respiratory depression includes assisted ventilation and/or administration of naloxone. Pregnancy: no contra-indication. The newborn infant may develop withdrawal symptoms, respiratory depression and drowsiness in the event of prolonged administration of large doses at rd the end of the 3 trimester. In this event, closely monitor the newborn infant. Breast-feeding: use with caution, for a short period (2-3 days), at the lowest effective dose. Monitor the mother and the infant: in the event of excessive drowsiness, stop treatment.
Source pages 99, 100
Extracted information for CODEINE only.
30 mg codeine phosphate tablet
Source page 99
Child over 12 years and adult: 30 to 60 mg every 4 to 6 hours; maximum 240 mg daily
Source page 99
According to clinical evolution; as short as possible.
Source page 99
Extracted information for CODEINE only.
Administer an appropriate laxative (e.g. lactulose) if analgesic treatment continues more than 48 hours. In some countries, codeine is on the list of narcotics: follow national regulations.
Source page 100
- Below 25 °C
Source page 100
Filter the extracted dose blocks for this individual drug.
30 to 60 mg every 4 to 6 hours; maximum 240 mg daily
Candidate age grouping · source page 99